Thursday, November 15, 2018 6:36:22 PM
Here's a small blurb about litigation financing from a company who provides it from the internet:
"Commercial litigation funding liberates a company to use its capital for corporate purposes; we fund fees and expenses associated with monetizing a legal claim and can also provide capital to maintain operations. Our litigation funding is non-recourse. If the underlying claim is unsuccessful, we are owed nothing."
For ERHC to secure litigation financing, their claim has to be pretty strong ... because litigation funding is NON-RECOURSE. Why would a litigation funder fund ANYTHING if there wasn't a strong case...or risk losing being paid back? Plus now they have a stake in making sure that the legal claim comes to fruition.
Granted litigation financing can be a very expensive cost of capital (perhaps they can take half of the claim)...but they may even get operating capital from the funding...which allows them to survive - see quoted paragraph above.
Krombacher
Recent ERHE News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/06/2024 07:31:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:06:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 05:35:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM